133 related articles for article (PubMed ID: 33826056)
1. Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane.
Saepang K; Li SK; Chantasart D
Pharm Res; 2021 Apr; 38(4):657-668. PubMed ID: 33826056
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pulsed Direct Current on Iontophoretic Delivery of Pramipexole across Human Epidermal Membrane In Vitro.
Saepang K; Li SK; Chantasart D
Pharm Res; 2021 Jul; 38(7):1187-1198. PubMed ID: 34136986
[TBL] [Abstract][Full Text] [Related]
3. Passive and iontophoretic transport of pramipexole dihydrochloride across human skin microchannels created by microneedles in vitro.
Saepang K; Li SK; Chantasart D
Int J Pharm; 2021 Nov; 609():121092. PubMed ID: 34530098
[TBL] [Abstract][Full Text] [Related]
4. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
Nugroho AK; Li GL; Danhof M; Bouwstra JA
Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
[TBL] [Abstract][Full Text] [Related]
5. Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.
Xu Q; Ibrahim SA; Higuchi WI; Li SK
Int J Pharm; 2009 Mar; 369(1-2):105-13. PubMed ID: 19041698
[TBL] [Abstract][Full Text] [Related]
6. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
[TBL] [Abstract][Full Text] [Related]
7. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
[TBL] [Abstract][Full Text] [Related]
8. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
9. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease.
Kalaria DR; Singhal M; Patravale V; Merino V; Kalia YN
Eur J Pharm Biopharm; 2018 Jun; 127():204-212. PubMed ID: 29477356
[TBL] [Abstract][Full Text] [Related]
11. Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro-mechanism.
Li Y; Wang D; Lu S; Zeng L; Wang Y; Song W; Liu J
Eur J Pharm Sci; 2018 Nov; 124():80-88. PubMed ID: 30076954
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.
Altenbach M; Schnyder N; Zimmermann C; Imanidis G
Int J Pharm; 2006 Jan; 307(2):308-17. PubMed ID: 16310991
[TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
14. Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis.
Akomeah FK; Martin GP; Brown MB
Int J Pharm; 2009 Feb; 367(1-2):162-8. PubMed ID: 18950696
[TBL] [Abstract][Full Text] [Related]
15. Convective solvent flow across the skin during iontophoresis.
Kim A; Green PG; Rao G; Guy RH
Pharm Res; 1993 Sep; 10(9):1315-20. PubMed ID: 8234169
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the permselective properties of rabbit skin during transdermal iontophoresis.
Nicoli S; Cappellazzi M; Colombo P; Santi P
J Pharm Sci; 2003 Jul; 92(7):1482-8. PubMed ID: 12820152
[TBL] [Abstract][Full Text] [Related]
17. An extended model based on the modified Nernst-Planck equation for describing transdermal iontophoresis of weak electrolytes.
Imanidis G; Luetolf P
J Pharm Sci; 2006 Jul; 95(7):1434-47. PubMed ID: 16724334
[TBL] [Abstract][Full Text] [Related]
18. Influence of lipids on the mannitol flux during transdermal iontophoresis in vitro.
Kirjavainen M; Urtti A; Mönkkönen J; Hirvonen J
Eur J Pharm Sci; 2000 Apr; 10(2):97-102. PubMed ID: 10727874
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
20. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo.
Singhal M; Serna C; Merino V; Kalia YN
Eur J Pharm Biopharm; 2021 Sep; 166():175-181. PubMed ID: 34175373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
